---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-241639"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:21:36.524526+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# EyePoint raises ~$150M in public offering to fund DURAVYU clinical development

## Summary
- Pricing: 11M shares at $12.00 each; 1.5M pre-funded warrants at $11.999 each.
- Gross proceeds ~$150M; net proceeds after underwriting discounts ~$141M.
- Net proceeds to advance DURAVYU for wet AMD and DME, plus pipeline and general purposes.
- Underwriters have 30-day option for up to 1,875,000 additional shares at $12.00.
- Offering closed on October 16, 2025.

## SEC filing metadata
- accession: 0001193125-25-241639
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/0001193125-25-241639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/d98837d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-241639
- JSON: https://secwatch.observer/filing/0001193125-25-241639.json
- Plain text: https://secwatch.observer/filing/0001193125-25-241639.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.